Literature DB >> 27836486

Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

Rachel A Cliburn1, Amy R Dunn2, Kristen A Stout2, Carlie A Hoffman2, Kelly M Lohr2, Alison I Bernstein2, Emily J Winokur2, James Burkett2, Yvonne Schmitz3, William M Caudle2, Gary W Miller4.   

Abstract

Vesicular monoamine transporter 2 (VMAT2, SLC18A2) is a transmembrane transporter protein that packages dopamine, serotonin, norepinephrine, and histamine into vesicles in preparation for neurotransmitter release from the presynaptic neuron. VMAT2 function and related vesicle dynamics have been linked to susceptibility to oxidative stress, exogenous toxicants, and Parkinson's disease. To address a recent depletion of commonly used antibodies to VMAT2, we generated and characterized a novel rabbit polyclonal antibody generated against a 19 amino acid epitope corresponding to an antigenic sequence within the C-terminal tail of mouse VMAT2. We used genetic models of altered VMAT2 expression to demonstrate that the antibody specifically recognizes VMAT2 and localizes to synaptic vesicles. Furthermore, immunohistochemical labeling using this VMAT2 antibody produces immunoreactivity that is consistent with expected VMAT2 regional distribution. We show the distribution of VMAT2 in monoaminergic brain regions of mouse brain, notably the midbrain, striatum, olfactory tubercle, dopaminergic paraventricular nuclei, tuberomammillary nucleus, raphe nucleus, and locus coeruleus. Normal neurotransmitter vesicle dynamics are critical for proper health and functioning of the nervous system, and this well-characterized VMAT2 antibody will be a useful tool in studying neurodegenerative and neuropsychiatric conditions characterized by vesicular dysfunction.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Antibody; Brain; Immunochemistry; Localization; Monoamine; VMAT2; Vesicle; Vesicular monoamine transporter 2

Mesh:

Substances:

Year:  2016        PMID: 27836486      PMCID: PMC5878016          DOI: 10.1016/j.jchemneu.2016.11.003

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  57 in total

1.  Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.

Authors:  Martin Anlauf; Martin K-H Schäfer; Thorsten Schwark; Nicole von Wurmb-Schwark; Viktoria Brand; Bence Sipos; Hans-Peter Horny; Reza Parwaresch; Wolfgang Hartschuh; Lee E Eiden; Günter Klöppel; Eberhard Weihe
Journal:  J Histochem Cytochem       Date:  2005-08-22       Impact factor: 2.479

2.  Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease.

Authors:  Jason R Richardson; W Michael Caudle; Minzheng Wang; E Danielle Dean; Kurt D Pennell; Gary W Miller
Journal:  FASEB J       Date:  2006-06-29       Impact factor: 5.191

Review 3.  Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances.

Authors:  Farrukh A Chaudhry; Robert H Edwards; Frode Fonnum
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 4.  Altered vesicular dopamine storage in Parkinson's disease: a premature demise.

Authors:  W Michael Caudle; Rebecca E Colebrooke; Piers C Emson; Gary W Miller
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

Review 5.  Vesicular neurotransmitter transporters: from bacteria to humans.

Authors:  S Schuldiner; A Shirvan; M Linial
Journal:  Physiol Rev       Date:  1995-04       Impact factor: 37.312

6.  Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.

Authors:  Chang-Hyun Song; Xueliang Fan; Cicely J Exeter; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2012-05-31       Impact factor: 5.996

7.  Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

Authors:  Y M Wang; R R Gainetdinov; F Fumagalli; F Xu; S R Jones; C B Bock; G W Miller; R M Wightman; M G Caron
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

8.  Effect of tyrosine on attention deficit disorder with hyperactivity.

Authors:  J Eisenberg; G M Asnis; H M van Praag; R M Vela
Journal:  J Clin Psychiatry       Date:  1988-05       Impact factor: 4.384

9.  Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.

Authors:  E Weihe; M K Schäfer; J D Erickson; L E Eiden
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

10.  Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.

Authors:  Kelly M Lohr; Merry Chen; Carlie A Hoffman; Miranda J McDaniel; Kristen A Stout; Amy R Dunn; Minzheng Wang; Alison I Bernstein; Gary W Miller
Journal:  Toxicol Sci       Date:  2016-06-10       Impact factor: 4.849

View more
  13 in total

1.  Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits.

Authors:  Aysegul O Gezer; Joseph Kochmanski; Sarah E VanOeveren; Allyson Cole-Strauss; Christopher J Kemp; Joseph R Patterson; Kathryn M Miller; Nathan C Kuhn; Danielle E Herman; Alyssa McIntire; Jack W Lipton; Kelvin C Luk; Sheila M Fleming; Caryl E Sortwell; Alison I Bernstein
Journal:  Neurobiol Dis       Date:  2020-05-15       Impact factor: 5.996

2.  Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.

Authors:  Eric E Beier; Matthew Neal; Gelerah Alam; Melissa Edler; Long-Jun Wu; Jason R Richardson
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

3.  VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation.

Authors:  Willemieke M Kouwenhoven; Guillaume Fortin; Anna-Maija Penttinen; Clélia Florence; Benoît Delignat-Lavaud; Marie-Josée Bourque; Thorsten Trimbuch; Milagros Pereira Luppi; Alix Salvail-Lacoste; Pascale Legault; Jean-François Poulin; Christian Rosenmund; Raj Awatramani; Louis-Éric Trudeau
Journal:  J Neurosci       Date:  2020-09-14       Impact factor: 6.167

4.  Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.

Authors:  Francesco Longo; Daniela Mercatelli; Salvatore Novello; Ludovico Arcuri; Alberto Brugnoli; Fabrizio Vincenzi; Isabella Russo; Giulia Berti; Omar S Mabrouk; Robert T Kennedy; Derya R Shimshek; Katia Varani; Luigi Bubacco; Elisa Greggio; Michele Morari
Journal:  Acta Neuropathol Commun       Date:  2017-03-14       Impact factor: 7.801

5.  5-HTR2A and 5-HTR3A but not 5-HTR1A antagonism impairs the cross-modal reactivation of deprived visual cortex in adulthood.

Authors:  Nathalie Lombaert; Maroussia Hennes; Sara Gilissen; Giel Schevenels; Laetitia Aerts; Ria Vanlaer; Lieve Geenen; Ann Van Eeckhaut; Ilse Smolders; Julie Nys; Lutgarde Arckens
Journal:  Mol Brain       Date:  2018-11-06       Impact factor: 4.041

6.  Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.

Authors:  Nicolas Giguère; Benoît Delignat-Lavaud; Freja Herborg; Aurore Voisin; Yuan Li; Vincent Jacquemet; Madhu Anand-Srivastava; Ulrik Gether; Bruno Giros; Louis-Éric Trudeau
Journal:  PLoS Genet       Date:  2019-08-26       Impact factor: 5.917

7.  Vesicular monoamine transporter 2 mediates fear behavior in mice.

Authors:  Rachel C Branco; James P Burkett; Carlie A Black; Emily Winokur; William Ellsworth; Rohan K Dhamsania; Kelly M Lohr; Jason P Schroeder; David Weinshenker; Tanja Jovanovic; Gary W Miller
Journal:  Genes Brain Behav       Date:  2020-01-14       Impact factor: 3.449

8.  Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains.

Authors:  Troels Rahbek-Clemmensen; Matthew D Lycas; Simon Erlendsson; Jacob Eriksen; Mia Apuschkin; Frederik Vilhardt; Trine N Jørgensen; Freja H Hansen; Ulrik Gether
Journal:  Nat Commun       Date:  2017-09-29       Impact factor: 14.919

9.  A Neurodevelopmental Model of Combined Pyrethroid and Chronic Stress Exposure.

Authors:  Aimée I Vester; Merry Chen; Carmen J Marsit; W Michael Caudle
Journal:  Toxics       Date:  2019-05-02

Review 10.  Neurochemical organization of the ventral striatum's olfactory tubercle.

Authors:  Hillary L Cansler; Katherine N Wright; Lucas A Stetzik; Daniel W Wesson
Journal:  J Neurochem       Date:  2020-01-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.